|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1996-5-21
|
|
pubmed:abstractText |
Interleukin-10 (IL-10) is a potent inhibitor of the proinflammatory cytokines, including tumor necrosis factor alpha and IL-1, which are considered important in the pathogenesis of rheumatoid arthritis (RA). The study was undertaken to establish whether IL-10 can ameliorate arthritis in the collagen-induced arthritis (CIA) model of RA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
495-503
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8607899-Animals,
pubmed-meshheading:8607899-Arthritis, Experimental,
pubmed-meshheading:8607899-Cattle,
pubmed-meshheading:8607899-Collagen,
pubmed-meshheading:8607899-Disease Models, Animal,
pubmed-meshheading:8607899-Dose-Response Relationship, Immunologic,
pubmed-meshheading:8607899-Drug Combinations,
pubmed-meshheading:8607899-Interleukin-10,
pubmed-meshheading:8607899-Male,
pubmed-meshheading:8607899-Mice,
pubmed-meshheading:8607899-Mice, Inbred DBA,
pubmed-meshheading:8607899-Recombinant Proteins,
pubmed-meshheading:8607899-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Interleukin-10 inhibition of the progression of established collagen-induced arthritis.
|
|
pubmed:affiliation |
Kennedy Institute of Rheumatology, London, England.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
